Erin Schumaker

2 weeks ago | politico.com | Erin Schumaker |Ruth Reader

NIH Director Jay Bhattacharya and Sen. Tammy Baldwin (D-Wis.) sparred over a proposal in the White House budget plan to give more grant recipients their money up front during a Senate Appropriations panel hearing on the agency’s budget Tuesday. At the hearing, Baldwin asked Bhattacharya to explain the proposal’s “forward-funding scheme,” which she said would result in even deeper cuts to the NIH than the 40 percent cut proposed by the White House.

2 weeks ago | politico.com | Erin Schumaker

With Carmen Paun and Robert King Secretary of State Marco Rubio has suggested Democrats' PEPFAR concerns are overblown, claiming the program remains “85 percent operative.” | Francis Chung/POLITICO SHOW ME THE MONEY —Democrats are sparring with Secretary of State Marco Rubio over the President’s Emergency Plan for AIDS Relief, the HIV and AIDS program credited with saving millions of lives in poor countries, Carmen, Amanda Friedman and Robert report.

3 weeks ago | politico.com | Erin Schumaker

National Academy of Sciences President Marcia McNutt made a plea to the nation’s science research community during her second annual State of the Science address in Washington on Tuesday: Course-correct or lose to China. We’re in the midst of a “radical new experiment,” McNutt explained, in which the U.S., by pursuing budget cuts, canceling grants and adopting restrictive research policies, serves as the treatment group, while China is the control.

1 month ago | politico.com | Erin Schumaker |Ruth Reader

Dr. Wafik El-Deiry, a cancer researcher and associate dean for oncology at Brown University, has an unlikely sales pitch for President Donald Trump: Pick me to lead the nation’s cancer research and give me a lot more money to spend on it. Despite slashing billions in health research grants and proposing further cuts in next year’s budget, Trump is considering El-Deiry to lead the National Cancer Institute after a recent interview for the job.

1 month ago | politico.com | Erin Schumaker

A well-known drug-policy lawyer is joining the Department of Health and Human Services to , according to two sources with knowledge of the move who requested anonymity because it hasn’t been announced yet, POLITICO’s Natalie Fertig reports. Matt Zorn, most recently a partner at Yetter Coleman, is listed in the HHS employee directory as deputy general counsel.